<div id="readability-page-1">Clinical trials are one of healthcare’s most powerful tools, and one of its most underutilized pathways to patient care and innovative therapies. Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment and making the path to new treatment options longer. Identifying and matching patients to the right clinical trial opportunity remains the single-largest cause of clinical trial delays, with many trials failing to meet their initial enrollment targets. But meeting an enrollment target doesn’t guarantee the right patients are represented, as trials consistently fall short of reflecting the communities that carry the greatest burden of disease. What are the biggest hurdles to patient participation? How has community-based clinical research bolstered patient-trial matching and the ability for trial populations to better reflect the intended patient population? How do innovative trial designs help achieve better science while accelerating patient access to new therapies? This Clinical Trials Day, join The Hill and Eli Lilly and Company (Lilly) to discuss how federal regulations and legislation can be modernized to eliminate regulatory and financial barriers to clinical research, ensuring that all patients — in urban, suburban, and rural communities alike — can participate in clinical trials as part of their healthcare journey. Following the afternoon’s programming, attendees are invited to step outside to the Woodrow Wilson Plaza, where two of Lilly’s Mobile Research Units (MRUs) will be stationed for live tours. The event is scheduled to begin at 3:30 p.m. ET.</div>

ELIS

The event 'Reimagining Clinical Trials' hosted by The Hill and Eli Lilly aims to address barriers to patient participation in clinical trials. It will explore how community-based research and innovative trial designs can enhance patient access and representation. The discussion will focus on modernizing federal regulations to facilitate participation from diverse communities. Attendees can tour Lilly's Mobile Research Units after the event, starting at 3:30 p.m. ET.

Thehill

Eli Lilly

Direxion Daily LLY Bear 1X Shares

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

VG Health

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

Proshares Ultra Nasdaq Biotech

Defiance Daily Target 2X Long LLY ETF

Direxion Daily LLY Bull 2X Shares

SPDR S&P Biotech

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

VanEck Biotech ETF

Watch live: Reimagining Clinical Trials – Expanding Access by Meeting Patients Where They Are